Evaluation of Approaches to Monitor Staphylococcus aureus Virulence Factor Expression during Human Disease

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Rozemeijer, Wouter ^a   Fink, Pamela ^b   Rojas, Eduardo ^b   Jones, C Hal ^b   Pavliakova, Danka ^b   Giardina, Peter ^b   Murphy, Ellen ^b   Liberator, Paul ^b   Jiang, Qin ^b   Girgenti, Douglas ^b   Peters, Remco P H ^a   Savelkoul, Paul H M ^a   Jansen, Kathrin U ^b   Anderson, Annaliesa S ^b   Kluytmans, Jan ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Vaccine Research East and Early Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN; RNA 16S; STAPHYLOCOCCUS VACCINE; CLFA PROTEIN, STAPHYLOCOCCUS AUREUS; COAGULASE; VIRULENCE FACTOR;

ANTIBIOTIC SENSITIVITY; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CAP5J GENE; CAP8J GENE; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION; GENOTYPE; HOUSEKEEPING GENE; ICAB GENE; MICROBIAL DIVERSITY; NONHUMAN; SEROLOGY; SPA GENE; STAPHYLOCOCCUS AUREUS; TPI GENE; WOUND INFECTION; ADULT; AGED; BACTERIAL CAPSULE; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; NOSE MUCOSA; PATHOGENICITY; SEROTYPE; STAPHYLOCOCCUS INFECTION; VERY ELDERLY;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL CAPSULES; COAGULASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL MUCOSA; SEROGROUP; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 84923765267     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116945     Document Type: Article

References (34)

1. Nathwani D (2009) Health economic issues in the treatment of drug-resistant serious Gram-positive infections. J Infect 59 Suppl 1: S40-50. doi: 10.1016/S0163-4453(09)60007-4 PMID: 19766889
2. Anderson AS, Scully IL, Timofeyeva Y, Murphy E, McNeil LK, et al. (2012) The Staphylococcus aureus transporter MntC is a highly conserved cell surface protein that elicits protective immunity against both S. aureus and Staphylococcus epidermidis. Journal of Infectious Diseases 205: 1688-1696. doi: 10. 1093/infdis/jis272 PMID: 22474033
3. Nanra JS, Buitrago SM, Crawford S, Ng J, Fink PS, et al. (2013) Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus. Hum Vaccin Immunother 9: 480-487. PMID: 23249887
4. Murphy E, Lin SL, Nunez L, Andrew L, Fink PS, et al. (2011) Challenges for the evaluation of Staphylococcus aureus protein based vaccines: monitoring antigenic diversity. Hum Vaccin 7 Suppl: 51-59. PMID: 21245656
5. Siboo IR, Cheung AL, Bayer AS, Sullam PM (2001) Clumping factor A mediates binding of Staphylococcus aureus to human platelets. Infect Immun 69: 3120-3127. PMID: 11292731
6. Handke LD, Hawkins JC, Miller AA, Jansen KU, Anderson AS (2013) Regulation of Staphylococcus aureus MntC Expression and Its Role in Response to Oxidative Stress. PLoS One 8: e77874. doi: 10. 1371/journal.pone.0077874 PMID: 24205007
7. O 'Gara JP (2007) ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol Lett 270: 179-188. PMID: 17419768
8. von Eiff C, Becker K, Machka K, Stammer H, Peters G (2001) Nasal Carriage as a Source of Staphylococcus aureus Bacteremia. New England Journal of Medicine 344: 11-16. PMID: 11136954
9. Wertheim HFL, Melles DC, Vos MC, van Leeuwen W, van Belkum A, et al. (2005) The role of nasal carriage in Staphylococcus aureus infections. The Lancet Infectious Diseases 5: 751-762. PMID: 16310147
10. Kluytmans JA, Mouton JW, Ijzerman EP, Vandenbroucke-Grauls CM, Maat AW, et al. (1995) Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 171: 216-219. PMID: 7798667
11. Kluytmans J, A van Belkum A, Verbrugh H (1997) Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 3: 505-520. PMID: 9227864
12. Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, et al. (2010) Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 362: 9-17. doi: 10.1056/NEJMoa0808939 PMID: 20054045
13. van Cleef BA, Kluytmans JA, van Benthem BH, Haenen A, Monen J, et al. (2012) Cross border comparison of MRSA bacteraemia between The Netherlands and North Rhine-Westphalia (Germany): a cross-sectional study. PLoS One 7: e42787. doi: 10.1371/journal.pone.0042787 PMID: 22880109
14. Harris SR, Cartwright EJ, Torok ME, Holden MT, Brown NM, et al. (2013) Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study. Lancet Infect Dis 13: 130-136. doi: 10.1016/S1473-3099(12)70268-2 PMID: 23158674
15. Blomfeldt A, Aamot HV, Eskesen AN, Muller F, Monecke S (2013) Molecular characterization of methi-cillin-sensitive Staphylococcus aureus isolates from bacteremic patients in a Norwegian University Hospital. J Clin Microbiol 51: 345-347. doi: 10.1128/JCM.02571-12 PMID: 23135934
16. Rasmussen G, Monecke S, Ehricht R, Soderquist B (2013) Prevalence of Clonal Complexes and Virulence Genes among Commensal and Invasive Staphylococcus aureus Isolates in Sweden. PLoS One 8: e77477. doi: 10.1371/journal.pone.0077477 PMID: 24130888
17. Nulens E, Stobberingh EE, van Dessel H, Sebastian S, van Tiel FH, et al. (2008) Molecular characterization of Staphylococcus aureus bloodstream isolates collected in a Dutch University Hospital between 1999 and 2006. J Clin Microbiol 46: 2438-2441. doi: 10.1128/JCM.00808-08 PMID: 18463215
18. Verkaik NJ, Boelens HA, de Vogel CP, Tavakol M, Bode LG, et al. (2010) Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 29: 509-518. doi: 10.1007/s10096-010-0888-0 PMID: 20186449
19. Burian M, Wolz C, Goerke C. (2010) Regulatory adaptation of Staphylococcus aureus during nasal colonization of humans. PLoS One 5: e10040. doi: 10.1371/journal.pone.0010040 PMID: 20386721
20. Date SV, Modrusan Z, Lawrence M, Morisaki JH, Toy K et al. (2014) Global gene expression of methi-cillin-resistant Staphylococcus aureusUSA300 during human and mouse infection. J Infect Dis 209: 1542-1550. doi: 10.1093/infdis/jit668 PMID: 24286981
21. Nanra JS, Timofeyeva Y, Buitrago SM, Sellman BR, Dilts DA, et al. (2009) Heterogeneous in vivo expression of clumping factor A and capsular polysaccharide by Staphylococcus aureus: implications for vaccine design. Vaccine 27: 3276-3280. doi: 10.1016/j.vaccine.2009.01.062 PMID: 19200819
22. Kuklin NA, Clark DJ, Secore S, Cook J, Cope LD, et al. (2006) A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. Infect Immun 74: 2215-2223. PMID: 16552052
23. Verkaik NJ, Dauwalder O, Antri K, Boubekri I, de Vogel CP, et al. (2010) Immunogenicity of toxins during Staphylococcus aureus infection. Clin Infect Dis 50: 61-68. doi: 10.1086/648673 PMID: 19947854
24. Verkaik NJ, Lebon A, de Vogel CP, Hooijkaas H, Verbrugh HA, et al. (2010) Induction of antibodies by Staphylococcus aureus nasal colonization in young children. Clin Microbiol Infect 16: 1312-1317. doi: 10.1111/j.1469-0691.2009.03073.x PMID: 19832714
25. Kolata J, Bode LG, Holtfreter S, Steil L, Kusch H, et al. (2011) Distinctive patterns in the human antibody response to Staphylococcus aureus bacteremia in carriers and non-carriers. Proteomics 11: 3914-3927. doi: 10.1002/pmic.201000760 PMID: 21805632
26. den Reijer PM, Lemmens-den Toom N, Kant S, Snijders SV, Boelens H, et al. (2013) Characterization of the Humoral Immune Response during Staphylococcus aureus Bacteremia and Global Gene Expression by Staphylococcus aureus in Human Blood. PLoS One 8: e53391. doi: 10.1371/journal.pone. 0053391 PMID: 23308212
27. Zorman JK, Esser M, Raedler M, Kreiswirth BN, Ala'aldeen DA, et al. (2013) Naturally occurring IgG antibody levels to the Staphylococcus aureus protein IsdB in humans. Hum Vaccin Immunother 9: 1857-1864. doi: 10.4161/hv.25253 PMID: 23778314
28. Hawkins J, Kodali S, Matsuka YV, McNeil LK, Mininni T, et al. (2012) A recombinant clumping factor Acontaining vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure. Clin Vaccine Immunol 19: 1641-1650. PMID: 22896688
29. Richmond P, Nissen M, Marshall H, Shakib S, Hodsman P, et al. (2011) A randomised, placebo controlled Phase 1 first-in-human study of a novel 3-antigen Staphylococcus aureus vaccine in healthy adults. ECCMID. Milan, Italy.
30. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG (2000) Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 38: 1008-1015. PMID: 10698988
31. Koreen L, Ramaswamy SV, Graviss EA, Naidich S, Musser JM, et al. (2004) spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. J Clin Microbiol 42: 792-799. PMID: 14766855
32. Mathema B, Mediavilla J, Kreiswirth BN (2008) Sequence analysis of the variable number tandem repeat in Staphylococcus aureus protein A gene: spa typing. Methods Mol Biol 431: 285-305. PMID: 18287764
33. Katoh K, Toh H (2008) Recent developments in the MAFFT multiple sequence alignment program. Brief Bioinform 9: 286-298. doi: 10.1093/bib/bbn013 PMID: 18372315
34. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599. PMID: 17488738